Literature DB >> 21312055

Characterization of apoptosis and proliferation in esophageal carcinoma EC109 cells following siRNA-induced down-regulation of TRAF6.

Tianzhong Ma1, Ning Wang, Zhongjing Su, Ling Chen, Ningxia Zhu, Changhui Ma, Xiancai Chen, Haibin Chen.   

Abstract

Tumor necrosis factor receptor-associated factor 6 (TRAF6) is an activator of the NF-κB transcription factor. NF-κB is involved in a variety of inflammatory, anti-apoptotic, and gene regulatory pathways and was recently found to be over-expressed in esophageal cancer cells. Here we investigated the function of TRAF6 in the esophageal cancer cell line EC109. siRNA targeting TRAF6 was introduced into EC109 cells and TRAF6 mRNA and protein levels were subsequently examined via RT-PCR and western blotting. Rates of apoptosis and cell proliferation were also measured using flow cytometry, ethynyl deoxyuridine (EdU), and CCK-8 (Cell Counting Kit-8) assays. The real-time PCR array was applied to profile the expression of TRAF6 related genes. TRAF6-siRNA reduced TRAF6 mRNA and protein expressions. NF-κB p65 protein expression was decreased in TRAF6-targeting siRNA-transfected cells compared to cells of the negative control. TRAF6-siRNA also significantly inhibited proliferation and enhanced apoptosis of EC109 cells. These studies suggested that TRAF6 was required for NF-κB activation in EC109 cells and it may be a good molecular target for suppressing the survival and proliferation of esophageal cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21312055     DOI: 10.1007/s11010-011-0741-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.

Authors:  Liming Wu; Hiroyasu Nakano; Zhenguo Wu
Journal:  J Biol Chem       Date:  2005-11-08       Impact factor: 5.157

Review 2.  Ubiquitin signalling in the NF-kappaB pathway.

Authors:  Zhijian J Chen
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

Review 3.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

4.  TRAF6 regulates cell fate decisions by inducing caspase 8-dependent apoptosis and the activation of NF-kappaB.

Authors:  Liusheng He; Xiaoli Wu; Richard Siegel; Peter E Lipsky
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

5.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

Review 6.  Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review).

Authors:  Deyin Xing; Wen Tan; Dongxin Lin
Journal:  Oncol Rep       Date:  2003 Sep-Oct       Impact factor: 3.906

7.  TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.

Authors:  Megumi Funakoshi-Tago; Noriyuki Kamada; Taeko Shimizu; Yusuke Hashiguchi; Kenji Tago; Yoshiko Sonoda; Tadashi Kasahara
Journal:  Cytokine       Date:  2008-12-16       Impact factor: 3.861

8.  Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B.

Authors:  S W Han; J Roman
Journal:  Oncogene       Date:  2006-03-06       Impact factor: 9.867

9.  A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function.

Authors:  Allison P Armstrong; Mark E Tometsko; Moira Glaccum; Claire L Sutherland; David Cosman; William C Dougall
Journal:  J Biol Chem       Date:  2002-08-15       Impact factor: 5.157

Review 10.  Novel RNA-based strategies for therapeutic gene silencing.

Authors:  Christopher R Sibley; Yiqi Seow; Matthew J A Wood
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

View more
  4 in total

1.  TNF receptor-associated factor 6 in advanced non-small cell lung cancer: clinical and prognostic implications.

Authors:  Hui Liu; Tiantuo Zhang; Jin Ye; Hongtao Li; Jing Huang; Xiaodong Li; Benquan Wu; Xubing Huang; Jinghui Hou
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-27       Impact factor: 4.553

2.  Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell.

Authors:  Lou Zhong; Fei Cao; Qingsheng You
Journal:  Tumour Biol       Date:  2012-10-04

3.  TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell.

Authors:  Qingbing Meng; Minqian Zheng; Hongbing Liu; Changzhi Song; Wensheng Zhang; Juan Yan; Ling Qin; Xiaolan Liu
Journal:  Mol Cell Biochem       Date:  2012-08-12       Impact factor: 3.396

4.  Expression and Clinical Significance of Tumor Necrosis Factor Receptor-Associated Factor 6 in Patients With Colon Cancer.

Authors:  Tao Zhang; Hui Wang; Liang Han
Journal:  Iran Red Crescent Med J       Date:  2016-01-23       Impact factor: 0.611

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.